fda halts glp-1 What Changed? The FDA's Clarification on Compounded Drugs 🚨 FDA Moves to Permanently

To address that gap, CMS launched a temporary Medicare GLP-1 Bridge program: starting July 1, 2026, eligible beneficiaries can access certain GLP-1 medications for about $50 per month, with eligibility tied to BMI thresholds (for example, a BMI of 35 or higher, or 27 or higher with other clinical criteria)

The GLP-1 formulation used in the referenced study is the same active ingredient as in FDA-approved Wegovy for chronic weight management

we have other tools to help you succeed with weight loss, including behavioral health and wellness, meal replacement shakes, and nutritional supplements

58 GLP-1RAs potentially may reduce the risk of AF onset and progression through direct and indirect effects on atrial remodelling, including a reduction in systemic inflammation, improvement of cardiomyocyte metabolism, autonomic nervous system modulation, regulation of intracellular Ca 2+ levels and prevention and possibly reversion of atrial fibrosis